comparemela.com

Latest Breaking News On - Samarendra mohanty - Page 6 : comparemela.com

Nanoscope Therapeutics Announces Five New Clinical and Scientific Advisory Board Appointments

/PRNewswire/ Nanoscope Therapeutics Inc, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced.

United statesUniversity of texas southwestern medical centerSamarendra mohantyJeff heierVittorio porciattiDan eramianStephen kaminskyDavids boyerPeter kaiserThomas yorioSteven grayPaul yangSrinivasr saddaStephenh tsangDrug administration for retinitis pigmentosaProfessor of research

Nanoscope s Vision Restoring Optogenetic Gene Therapy to be Featured in Four Presentations as part of SPIE Photonics West 2022 in San Francisco Jan 22-27, 2022

/PRNewswire/ Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing optogenetic gene therapies for the treatment of retinal.

United statesSan franciscoPsulagna bhattacharyaSamarendra mohantyDan eramianVivo neuromodulationMoscone centerOpus biotech communicationsNanoscope therapeutics incChief scientific officer samarendra mohantyOptogenetic vision restorationMulti characteristic opsinsBipolar cellsUltrafast laser based transient perforationCellular membranesUpper mezzanine south

Nanoscope s Vision Restoring Optogenetic Gene Therapy to be Featured in Four Presentations as part of SPIE Photonics West 2022 in San Francisco Jan 22-27, 2022

/PRNewswire/ Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing optogenetic gene therapies for the treatment of retinal.

United statesSan franciscoPsulagna bhattacharyaSamarendra mohantyDan eramianVivo neuromodulationMoscone centerOpus biotech communicationsNanoscope therapeutics incChief scientific officer samarendra mohantyOptogenetic vision restorationMulti characteristic opsinsBipolar cellsUltrafast laser based transient perforationCellular membranesUpper mezzanine south

Nanoscope Awarded Key U S Patent Protecting its Multi-Characteristic Opsin Gene Therapy Platform For Reversing Blindness

/PRNewswire/ Nanoscope Therapeutics Inc, a clinical-stage biotechnology company developing optogenetic gene therapies for retinal degenerative diseases,.

United statesSulagna battacharyaSamarendra mohantyDan eramianDrug administrationOpus biotech communicationsNanoscope therapeutics incMulti characteristic opsinMulti characteristic opsinsNanoscope therapeutics

78 North Texans Who Are Shaping the Future

Get to know the finalists in the 2022 Innovation Awards, brought to you by D CEO and Dallas Innovates. Winners will be revealed Jan. 12.

United statesFort worthLawrence schwartzDanielj scottAlvaro luqueSean studzinskiNicolas madsenJohn millsClint nolenRussell laughlinPerot jainKelseyj vanderschootAndrew schulzKelsey vanderschootJared popePrasad reddy

vimarsana © 2020. All Rights Reserved.